Visit the Chemometec web site
Click on the advert above to visit the company web site

Product category: Cell/tissue handling and counting
News Release from: Bionas | Subject: Bionas 2500
Edited by the Laboratorytalk Editorial Team on 09 November 2006

Cell profiling device chosen for target
validation

Request your FREE weekly copy of the Laboratorytalk email newsletter. News about Cell/tissue handling and counting and more every issue. Click here for details.

Bionas and Solvay Pharmaceuticals Research Laboratories report that the Bionas 2500 analysing system has been recognised to be a valuable tool for target validation studies

"It is known that angiotensin 1-8 (angiotensin II) acts via two receptors "The AT1 receptor mediates vasoconstriction upon stimulation, whereas the AT2 receptor is implicated in hypotensive effects

"However, the mechanism through which angiotensin 1-7 induces its powerful hypotensive effect were unclear," explains Eric Ronken, principal scientist at Solvay.

On-line monitoring of endothelial cell physiology and its changes upon challenges by angiotensin 1-7 helped in delineating the mechanism of action by this peptide.

The Bionas 2500 analysing system is well suited for such experiments, as it measures cellular acidification, oxygen consumption and cell adhesion simultaneously in a label-free and non-invasive way.

"The Bionas system allows us to extend and optimise target validation studies by bringing the targets back into their physiological context", says Ronken.

The Bionas 2500 analysing system gives a complete overview over the physiologic state of cells.

It can be used to discriminate between different signal transduction pathways allowing target validation studies at an early stage in the drug discovery process.

Recently, Bionas announced the usefulness of its device to predict liver toxicity in primary human hepatocytes and standardised HepG2 cells.

Bionas: contact details and other news
Email this article to a colleague
Register for the free Laboratorytalk email newsletter
Laboratorytalk Home Page

Search the Pro-Talk network of sites

Visit the Chemometec web site